Global Point of Care Infectious Disease Testing Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18750386

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18750386

Global Point of Care Infectious Disease Testing Databank Market Report

The Point of Care Infectious Disease Testing market was valued at $1,315.6 Million in 2022, and is projected to reach $2,143.6 Million by 2031 growing at a CAGR of 5.62% from 2023 to 2031. HIV POC segment is expected to be the highest contributor to this market, with $193.9 Million in 2022, and is anticipated to reach $303.6 Million by 2031, registering a CAGR of 5.16%. HSV (Herpes Simplex Virus) POC segment is anticipated to reach $105.8 Million by 2031 with the highest CAGR of 7.19%. HIV POC and Clostridium difficile POC segments collectively expected to account for about 28.1% share of the Point of Care Infectious Disease Testing market in 2022, with the former constituting around 14.7% share. HSV (Herpes Simplex Virus) POC and TB and drug-resistant TB POC segments are expected to witness significant growth rates at a CAGR of 7.19% and 6.79% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 9.2% in the overall Point of Care Infectious Disease Testing market in 2022, and is anticipated to reach 10.4% by 2031.

1. Global Point of Care Infectious Disease Testing Market, By Disease: 1.1. Overview; 1.2. HIV POC; 1.2.1 HIV POC Market, By Region; 1.2.1.1 North America HIV POC Market, By Country; 1.2.1.2 Europe HIV POC Market, By Country; 1.2.1.3 Asia-Pacific HIV POC Market, By Country; 1.2.1.4 Rest of World HIV POC Market, By Country; 1.3. Clostridium difficile POC; 1.3.1 Clostridium difficile POC Market, By Region; 1.3.1.1 North America Clostridium difficile POC Market, By Country; 1.3.1.2 Europe Clostridium difficile POC Market, By Country; 1.3.1.3 Asia-Pacific Clostridium difficile POC Market, By Country; 1.3.1.4 Rest of World Clostridium difficile POC Market, By Country; 1.4. HBV POC; 1.4.1 HBV POC Market, By Region; 1.4.1.1 North America HBV POC Market, By Country; 1.4.1.2 Europe HBV POC Market, By Country; 1.4.1.3 Asia-Pacific HBV POC Market, By Country; 1.4.1.4 Rest of World HBV POC Market, By Country; 1.5. Pneumonia or Streptococcus associated infections; 1.5.1 Pneumonia or Streptococcus associated infections Market, By Region; 1.5.1.1 North America Pneumonia or Streptococcus associated infections Market, By Country; 1.5.1.2 Europe Pneumonia or Streptococcus associated infections Market, By Country; 1.5.1.3 Asia-Pacific Pneumonia or Streptococcus associated infections Market, By Country; 1.5.1.4 Rest of World Pneumonia or Streptococcus associated infections Market, By Country; 1.6. Respiratory syncytial virus (RSV) POC; 1.6.1 Respiratory syncytial virus (RSV) POC Market, By Region; 1.6.1.1 North America Respiratory syncytial virus (RSV) POC Market, By Country; 1.6.1.2 Europe Respiratory syncytial virus (RSV) POC Market, By Country; 1.6.1.3 Asia-Pacific Respiratory syncytial virus (RSV) POC Market, By Country; 1.6.1.4 Rest of World Respiratory syncytial virus (RSV) POC Market, By Country; 1.7. HPV POC; 1.7.1 HPV POC Market, By Region; 1.7.1.1 North America HPV POC Market, By Country; 1.7.1.2 Europe HPV POC Market, By Country; 1.7.1.3 Asia-Pacific HPV POC Market, By Country; 1.7.1.4 Rest of World HPV POC Market, By Country; 1.8. Influenza/Flu POC; 1.8.1 Influenza/Flu POC Market, By Region; 1.8.1.1 North America Influenza/Flu POC Market, By Country; 1.8.1.2 Europe Influenza/Flu POC Market, By Country; 1.8.1.3 Asia-Pacific Influenza/Flu POC Market, By Country; 1.8.1.4 Rest of World Influenza/Flu POC Market, By Country; 1.9. HCV POC; 1.9.1 HCV POC Market, By Region; 1.9.1.1 North America HCV POC Market, By Country; 1.9.1.2 Europe HCV POC Market, By Country; 1.9.1.3 Asia-Pacific HCV POC Market, By Country; 1.9.1.4 Rest of World HCV POC Market, By Country; 1.10. MRSA POC; 1.10.1 MRSA POC Market, By Region; 1.10.1.1 North America MRSA POC Market, By Country; 1.10.1.2 Europe MRSA POC Market, By Country; 1.10.1.3 Asia-Pacific MRSA POC Market, By Country; 1.10.1.4 Rest of World MRSA POC Market, By Country; 1.11. TB and drug-resistant TB POC; 1.11.1 TB and drug-resistant TB POC Market, By Region; 1.11.1.1 North America TB and drug-resistant TB POC Market, By Country; 1.11.1.2 Europe TB and drug-resistant TB POC Market, By Country; 1.11.1.3 Asia-Pacific TB and drug-resistant TB POC Market, By Country; 1.11.1.4 Rest of World TB and drug-resistant TB POC Market, By Country; 1.12. HSV (Herpes Simplex Virus) POC; 1.12.1 HSV (Herpes Simplex Virus) POC Market, By Region; 1.12.1.1 North America HSV (Herpes Simplex Virus) POC Market, By Country; 1.12.1.2 Europe HSV (Herpes Simplex Virus) POC Market, By Country; 1.12.1.3 Asia-Pacific HSV (Herpes Simplex Virus) POC Market, By Country; 1.12.1.4 Rest of World HSV (Herpes Simplex Virus) POC Market, By Country; 1.13. Other infectious disease POC; 1.13.1 Other infectious disease POC Market, By Region; 1.13.1.1 North America Other infectious disease POC Market, By Country; 1.13.1.2 Europe Other infectious disease POC Market, By Country; 1.13.1.3 Asia-Pacific Other infectious disease POC Market, By Country; 1.13.1.4 Rest of World Other infectious disease POC Market, By Country
2. Global Point of Care Infectious Disease Testing Market, By End-Use: 2.1. Overview; 2.2. Hospitals; 2.2.1 Hospitals Market, By Region; 2.2.1.1 North America Hospitals Market, By Country; 2.2.1.2 Europe Hospitals Market, By Country; 2.2.1.3 Asia-Pacific Hospitals Market, By Country; 2.2.1.4 Rest of World Hospitals Market, By Country; 2.3. Clinics; 2.3.1 Clinics Market, By Region; 2.3.1.1 North America Clinics Market, By Country; 2.3.1.2 Europe Clinics Market, By Country; 2.3.1.3 Asia-Pacific Clinics Market, By Country; 2.3.1.4 Rest of World Clinics Market, By Country; 2.4. Home; 2.4.1 Home Market, By Region; 2.4.1.1 North America Home Market, By Country; 2.4.1.2 Europe Home Market, By Country; 2.4.1.3 Asia-Pacific Home Market, By Country; 2.4.1.4 Rest of World Home Market, By Country; 2.5. Assisted Living Healthcare Facilities; 2.5.1 Assisted Living Healthcare Facilities Market, By Region; 2.5.1.1 North America Assisted Living Healthcare Facilities Market, By Country; 2.5.1.2 Europe Assisted Living Healthcare Facilities Market, By Country; 2.5.1.3 Asia-Pacific Assisted Living Healthcare Facilities Market, By Country; 2.5.1.4 Rest of World Assisted Living Healthcare Facilities Market, By Country; 2.6. Laboratories; 2.6.1 Laboratories Market, By Region; 2.6.1.1 North America Laboratories Market, By Country; 2.6.1.2 Europe Laboratories Market, By Country; 2.6.1.3 Asia-Pacific Laboratories Market, By Country; 2.6.1.4 Rest of World Laboratories Market, By Country; 2.7. Other End-Uses; 2.7.1 Other End-Uses Market, By Region; 2.7.1.1 North America Other End-Uses Market, By Country; 2.7.1.2 Europe Other End-Uses Market, By Country; 2.7.1.3 Asia-Pacific Other End-Uses Market, By Country; 2.7.1.4 Rest of World Other End-Uses Market, By Country
3. Global Point of Care Infectious Disease Testing Market, By Region: 3.1. Overview; 3.2. North America; 3.2.1 North America Point of Care Infectious Disease Testing Market, By Disease; 3.2.2 North America Point of Care Infectious Disease Testing Market, By End-Use; 3.2.3 North America Point of Care Infectious Disease Testing Market, By Country; 3.2.3.1 U.S.; 3.2.3.1.1 U.S. Point of Care Infectious Disease Testing Market, By Disease; 3.2.3.1.2 U.S. Point of Care Infectious Disease Testing Market, By End-Use; 3.2.3.2 Canada; 3.2.3.2.1 Canada Point of Care Infectious Disease Testing Market, By Disease; 3.2.3.2.2 Canada Point of Care Infectious Disease Testing Market, By End-Use; 3.3. Europe; 3.3.1 Europe Point of Care Infectious Disease Testing Market, By Disease; 3.3.2 Europe Point of Care Infectious Disease Testing Market, By End-Use; 3.3.3 Europe Point of Care Infectious Disease Testing Market, By Country; 3.3.3.1 Germany; 3.3.3.1.1 Germany Point of Care Infectious Disease Testing Market, By Disease; 3.3.3.1.2 Germany Point of Care Infectious Disease Testing Market, By End-Use; 3.3.3.2 U.K.; 3.3.3.2.1 U.K. Point of Care Infectious Disease Testing Market, By Disease; 3.3.3.2.2 U.K. Point of Care Infectious Disease Testing Market, By End-Use; 3.3.3.3 France; 3.3.3.3.1 France Point of Care Infectious Disease Testing Market, By Disease; 3.3.3.3.2 France Point of Care Infectious Disease Testing Market, By End-Use; 3.3.3.4 Italy; 3.3.3.4.1 Italy Point of Care Infectious Disease Testing Market, By Disease; 3.3.3.4.2 Italy Point of Care Infectious Disease Testing Market, By End-Use; 3.3.3.5 Spain; 3.3.3.5.1 Spain Point of Care Infectious Disease Testing Market, By Disease; 3.3.3.5.2 Spain Point of Care Infectious Disease Testing Market, By End-Use; 3.3.3.6 Rest of Europe; 3.3.3.6.1 Rest of Europe Point of Care Infectious Disease Testing Market, By Disease; 3.3.3.6.2 Rest of Europe Point of Care Infectious Disease Testing Market, By End-Use; 3.4. Asia-Pacific; 3.4.1 Asia-Pacific Point of Care Infectious Disease Testing Market, By Disease; 3.4.2 Asia-Pacific Point of Care Infectious Disease Testing Market, By End-Use; 3.4.3 Asia-Pacific Point of Care Infectious Disease Testing Market, By Country; 3.4.3.1 China; 3.4.3.1.1 China Point of Care Infectious Disease Testing Market, By Disease; 3.4.3.1.2 China Point of Care Infectious Disease Testing Market, By End-Use; 3.4.3.2 Japan; 3.4.3.2.1 Japan Point of Care Infectious Disease Testing Market, By Disease; 3.4.3.2.2 Japan Point of Care Infectious Disease Testing Market, By End-Use; 3.4.3.3 South Korea; 3.4.3.3.1 South Korea Point of Care Infectious Disease Testing Market, By Disease; 3.4.3.3.2 South Korea Point of Care Infectious Disease Testing Market, By End-Use; 3.4.3.4 India; 3.4.3.4.1 India Point of Care Infectious Disease Testing Market, By Disease; 3.4.3.4.2 India Point of Care Infectious Disease Testing Market, By End-Use; 3.4.3.5 Singapore; 3.4.3.5.1 Singapore Point of Care Infectious Disease Testing Market, By Disease; 3.4.3.5.2 Singapore Point of Care Infectious Disease Testing Market, By End-Use; 3.4.3.6 Rest of Asia; 3.4.3.6.1 Rest of Asia Point of Care Infectious Disease Testing Market, By Disease; 3.4.3.6.2 Rest of Asia Point of Care Infectious Disease Testing Market, By End-Use; 3.5. Rest of World; 3.5.1 Rest of World Point of Care Infectious Disease Testing Market, By Disease; 3.5.2 Rest of World Point of Care Infectious Disease Testing Market, By End-Use; 3.5.3 Rest of World Point of Care Infectious Disease Testing Market, By Country; 3.5.3.1 Brazil; 3.5.3.1.1 Brazil Point of Care Infectious Disease Testing Market, By Disease; 3.5.3.1.2 Brazil Point of Care Infectious Disease Testing Market, By End-Use; 3.5.3.2 Mexico; 3.5.3.2.1 Mexico Point of Care Infectious Disease Testing Market, By Disease; 3.5.3.2.2 Mexico Point of Care Infectious Disease Testing Market, By End-Use; 3.5.3.3 South Africa; 3.5.3.3.1 South Africa Point of Care Infectious Disease Testing Market, By Disease; 3.5.3.3.2 South Africa Point of Care Infectious Disease Testing Market, By End-Use; 3.5.3.4 Australia; 3.5.3.4.1 Australia Point of Care Infectious Disease Testing Market, By Disease; 3.5.3.4.2 Australia Point of Care Infectious Disease Testing Market, By End-Use; 3.5.3.5 ROW Countries; 3.5.3.5.1 ROW Countries Point of Care Infectious Disease Testing Market, By Disease; 3.5.3.5.2 ROW Countries Point of Care Infectious Disease Testing Market, By End-Use; ROW Countries Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 2. HIV POC Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America HIV POC Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe HIV POC Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific HIV POC Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World HIV POC Market Value, By Country, 2022-2031, Million USD; TABLE 7. Clostridium difficile POC Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America Clostridium difficile POC Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe Clostridium difficile POC Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific Clostridium difficile POC Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World Clostridium difficile POC Market Value, By Country, 2022-2031, Million USD; TABLE 12. HBV POC Market Value, By Region, 2022-2031, Million USD; TABLE 13. North America HBV POC Market Value, By Country, 2022-2031, Million USD; TABLE 14. Europe HBV POC Market Value, By Country, 2022-2031, Million USD; TABLE 15. Asia-Pacific HBV POC Market Value, By Country, 2022-2031, Million USD; TABLE 16. Rest of World HBV POC Market Value, By Country, 2022-2031, Million USD; TABLE 17. Pneumonia or Streptococcus associated infections Market Value, By Region, 2022-2031, Million USD; TABLE 18. North America Pneumonia or Streptococcus associated infections Market Value, By Country, 2022-2031, Million USD; TABLE 19. Europe Pneumonia or Streptococcus associated infections Market Value, By Country, 2022-2031, Million USD; TABLE 20. Asia-Pacific Pneumonia or Streptococcus associated infections Market Value, By Country, 2022-2031, Million USD; TABLE 21. Rest of World Pneumonia or Streptococcus associated infections Market Value, By Country, 2022-2031, Million USD; TABLE 22. Respiratory syncytial virus (RSV) POC Market Value, By Region, 2022-2031, Million USD; TABLE 23. North America Respiratory syncytial virus (RSV) POC Market Value, By Country, 2022-2031, Million USD; TABLE 24. Europe Respiratory syncytial virus (RSV) POC Market Value, By Country, 2022-2031, Million USD; TABLE 25. Asia-Pacific Respiratory syncytial virus (RSV) POC Market Value, By Country, 2022-2031, Million USD; TABLE 26. Rest of World Respiratory syncytial virus (RSV) POC Market Value, By Country, 2022-2031, Million USD; TABLE 27. HPV POC Market Value, By Region, 2022-2031, Million USD; TABLE 28. North America HPV POC Market Value, By Country, 2022-2031, Million USD; TABLE 29. Europe HPV POC Market Value, By Country, 2022-2031, Million USD; TABLE 30. Asia-Pacific HPV POC Market Value, By Country, 2022-2031, Million USD; TABLE 31. Rest of World HPV POC Market Value, By Country, 2022-2031, Million USD; TABLE 32. Influenza/Flu POC Market Value, By Region, 2022-2031, Million USD; TABLE 33. North America Influenza/Flu POC Market Value, By Country, 2022-2031, Million USD; TABLE 34. Europe Influenza/Flu POC Market Value, By Country, 2022-2031, Million USD; TABLE 35. Asia-Pacific Influenza/Flu POC Market Value, By Country, 2022-2031, Million USD; TABLE 36. Rest of World Influenza/Flu POC Market Value, By Country, 2022-2031, Million USD; TABLE 37. HCV POC Market Value, By Region, 2022-2031, Million USD; TABLE 38. North America HCV POC Market Value, By Country, 2022-2031, Million USD; TABLE 39. Europe HCV POC Market Value, By Country, 2022-2031, Million USD; TABLE 40. Asia-Pacific HCV POC Market Value, By Country, 2022-2031, Million USD; TABLE 41. Rest of World HCV POC Market Value, By Country, 2022-2031, Million USD; TABLE 42. MRSA POC Market Value, By Region, 2022-2031, Million USD; TABLE 43. North America MRSA POC Market Value, By Country, 2022-2031, Million USD; TABLE 44. Europe MRSA POC Market Value, By Country, 2022-2031, Million USD; TABLE 45. Asia-Pacific MRSA POC Market Value, By Country, 2022-2031, Million USD; TABLE 46. Rest of World MRSA POC Market Value, By Country, 2022-2031, Million USD; TABLE 47. TB and drug-resistant TB POC Market Value, By Region, 2022-2031, Million USD; TABLE 48. North America TB and drug-resistant TB POC Market Value, By Country, 2022-2031, Million USD; TABLE 49. Europe TB and drug-resistant TB POC Market Value, By Country, 2022-2031, Million USD; TABLE 50. Asia-Pacific TB and drug-resistant TB POC Market Value, By Country, 2022-2031, Million USD; TABLE 51. Rest of World TB and drug-resistant TB POC Market Value, By Country, 2022-2031, Million USD; TABLE 52. HSV (Herpes Simplex Virus) POC Market Value, By Region, 2022-2031, Million USD; TABLE 53. North America HSV (Herpes Simplex Virus) POC Market Value, By Country, 2022-2031, Million USD; TABLE 54. Europe HSV (Herpes Simplex Virus) POC Market Value, By Country, 2022-2031, Million USD; TABLE 55. Asia-Pacific HSV (Herpes Simplex Virus) POC Market Value, By Country, 2022-2031, Million USD; TABLE 56. Rest of World HSV (Herpes Simplex Virus) POC Market Value, By Country, 2022-2031, Million USD; TABLE 57. Other infectious disease POC Market Value, By Region, 2022-2031, Million USD; TABLE 58. North America Other infectious disease POC Market Value, By Country, 2022-2031, Million USD; TABLE 59. Europe Other infectious disease POC Market Value, By Country, 2022-2031, Million USD; TABLE 60. Asia-Pacific Other infectious disease POC Market Value, By Country, 2022-2031, Million USD; TABLE 61. Rest of World Other infectious disease POC Market Value, By Country, 2022-2031, Million USD; TABLE 62. Global Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 63. Hospitals Market Value, By Region, 2022-2031, Million USD; TABLE 64. North America Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 65. Europe Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 66. Asia-Pacific Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 67. Rest of World Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 68. Clinics Market Value, By Region, 2022-2031, Million USD; TABLE 69. North America Clinics Market Value, By Country, 2022-2031, Million USD; TABLE 70. Europe Clinics Market Value, By Country, 2022-2031, Million USD; TABLE 71. Asia-Pacific Clinics Market Value, By Country, 2022-2031, Million USD; TABLE 72. Rest of World Clinics Market Value, By Country, 2022-2031, Million USD; TABLE 73. Home Market Value, By Region, 2022-2031, Million USD; TABLE 74. North America Home Market Value, By Country, 2022-2031, Million USD; TABLE 75. Europe Home Market Value, By Country, 2022-2031, Million USD; TABLE 76. Asia-Pacific Home Market Value, By Country, 2022-2031, Million USD; TABLE 77. Rest of World Home Market Value, By Country, 2022-2031, Million USD; TABLE 78. Assisted Living Healthcare Facilities Market Value, By Region, 2022-2031, Million USD; TABLE 79. North America Assisted Living Healthcare Facilities Market Value, By Country, 2022-2031, Million USD; TABLE 80. Europe Assisted Living Healthcare Facilities Market Value, By Country, 2022-2031, Million USD; TABLE 81. Asia-Pacific Assisted Living Healthcare Facilities Market Value, By Country, 2022-2031, Million USD; TABLE 82. Rest of World Assisted Living Healthcare Facilities Market Value, By Country, 2022-2031, Million USD; TABLE 83. Laboratories Market Value, By Region, 2022-2031, Million USD; TABLE 84. North America Laboratories Market Value, By Country, 2022-2031, Million USD; TABLE 85. Europe Laboratories Market Value, By Country, 2022-2031, Million USD; TABLE 86. Asia-Pacific Laboratories Market Value, By Country, 2022-2031, Million USD; TABLE 87. Rest of World Laboratories Market Value, By Country, 2022-2031, Million USD; TABLE 88. Other End-Uses Market Value, By Region, 2022-2031, Million USD; TABLE 89. North America Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 90. Europe Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 91. Asia-Pacific Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 92. Rest of World Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 93. Global Point of Care Infectious Disease Testing Market Value, By Region, 2022-2031, Million USD; TABLE 94. North America Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 95. North America Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 96. North America Point of Care Infectious Disease Testing Market Value, By Country, 2022-2031, Million USD; TABLE 97. U.S. Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 98. U.S. Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 99. Canada Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 100. Canada Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 101. Europe Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 102. Europe Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 103. Europe Point of Care Infectious Disease Testing Market Value, By Country, 2022-2031, Million USD; TABLE 104. Germany Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 105. Germany Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 106. U.K. Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 107. U.K. Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 108. France Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 109. France Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 110. Italy Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 111. Italy Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 112. Spain Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 113. Spain Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 114. Rest of Europe Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 115. Rest of Europe Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 116. Asia-Pacific Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 117. Asia-Pacific Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 118. Asia-Pacific Point of Care Infectious Disease Testing Market Value, By Country, 2022-2031, Million USD; TABLE 119. China Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 120. China Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 121. Japan Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 122. Japan Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 123. South Korea Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 124. South Korea Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 125. India Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 126. India Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 127. Singapore Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 128. Singapore Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 129. Rest of Asia Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 130. Rest of Asia Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 131. Rest of World Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 132. Rest of World Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 133. Rest of World Point of Care Infectious Disease Testing Market Value, By Country, 2022-2031, Million USD; TABLE 134. Brazil Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 135. Brazil Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 136. Mexico Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 137. Mexico Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 138. South Africa Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 139. South Africa Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 140. Australia Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 141. Australia Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; TABLE 142. ROW Countries Point of Care Infectious Disease Testing Market Value, By Disease, 2022-2031, Million USD; TABLE 143. ROW Countries Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD; ROW Countries Point of Care Infectious Disease Testing Market Value, By End-Use, 2022-2031, Million USD